UC Berkeley study finds cocaine can dominate high-level brain circuits

Published on August 26, 2013 at 12:49 AM · No Comments

Cocaine can speedily rewire high-level brain circuits that support learning, memory and decision-making, according to new research from the University of California, Berkeley, and UCSF. The findings shed new light on the frontal brain's role in drug-seeking behavior and may be key to tackling addiction.

Looking into the frontal lobes of live mice at a cellular level, researchers found that, after just one dose of cocaine, the rodents showed fast and robust growth of dendritic spines, which are tiny, twig-like structures that connect neurons and form the nodes of the brain's circuit wiring.

"Our images provide clear evidence that cocaine induces rapid gains in new spines, and the more spines the mice gain, the more they show they learned about the drug," said Linda Wilbrecht, assistant professor of psychology and neuroscience at UC Berkeley and lead author of the paper to be published August 25 in the journal Nature Neuroscience.

For mice, "learning about the drug" can mean seeking it out to the exclusion of meeting other needs, which may explain how addiction in humans can override other considerations that are necessary for a balanced life: "The downside is, you might be learning too well about drugs at the expense of other things," Wilbrecht said.

Using a technology known as 2-photon laser scanning microscopy, researchers made images of nerve cell connections in the frontal cortices of live mice before and after the mice received their first dose of cocaine and, within just two hours, observed the formation of new dendritic spines.

"The number of new, robust spines gained correlated with how much the individual mice learned to prefer the context in which they received the drug," Wilbrecht said. The findings provide clues to behavioral and environmental factors in drug addiction.

Previous analyses of postmortem mouse brains have shown that repeated cocaine use and withdrawal changes dendritic spine density after weeks of exposure. But this is the first time that 2-photon laser scanning microscopy has been used to make images of spines in the frontal cortex before and after the first cocaine exposure in living mice, Wilbrecht said.

Over the course of a few days, male mice were moved from their cages to a "conditioning box" comprised of two adjoining compartments. Each chamber - one smelled of cinnamon and the other of vanilla - was decorated with different patterns and textures so the mice could differentiate between the two.

Initially, the mice were free to explore both chambers, which were connected by a small doorway. Researchers recorded which side each mouse preferred. The next day, the mice were injected with saline, which has no stimulant effect on mice, and were placed for 15 minutes in the compartment for which they had shown a preference. The door between the two chambers was shut.

The following day, they were injected with cocaine and placed in the chamber that was not their preferred side. Again, the door between the two chambers was shut and they were inside for 15 minutes. On the fourth day, the door between the two chambers was open, yet the mice overwhelmingly picked the chamber where they had received and presumably enjoyed the cocaine.

"When given a choice, most of the mice preferred to explore the side where they had the cocaine, which indicated that they were looking for more cocaine," Wilbrecht said. "Their change in preference for the cocaine side correlated with gains in new persistent spines that appeared on the day they experienced cocaine."

According to Wilbrecht, "These drug-induced changes in the brain may explain how drug related cues come to dominate decision-making in a human drug user, leaving more mundane tasks and cues with relatively less power to activate the brain's decision-making centers."

Much of the research was conducted at the Ernest Gallo Clinic and Research Center at UCSF. Other co-authors of the study are Francisco Javier Munoz-Cuevas and Jegath Athilingam from the Ernest Gallo Clinic and Research Center and Denise Piscopo of the University of Oregon.

Posted in: Medical Science News | Medical Research News

Tags: , , , , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Scientists find a new strategy for brain cancer treatment